Two Cambridge cancer drug startups score big funding rounds
December 14, 2017 at 07:00 AM EST
Kyn Therapeutics emerged from stealth mode on Thursday with $49 million in financing, while Relay Therapeutics announced a $63 million Series B round. The companies are pursuing cancer treatments in different — and unique — ways.
